Addex Therapeutics

(NASDAQ) ADXN

Current Price$6.96

Market Cap$8.80M

Since IPO (2020)-98%

5 Year-96%

1 Year-18%

1 Month+11%

Addex Therapeutics Financials at a Glance

Market Cap

$8.80M

Revenue (TTM)

$208.29K

Net Income (TTM)

$6.72M

EPS (TTM)

$-8.70

P/E Ratio

-0.80

Dividend

$0.00

Beta (Volatility)

0.38 (Low)

Dividend

$0.00

Beta (Volatility)

0.38 (Low)

Price

$6.96

Volume

Open

$6.96

Price

$6.96

Volume

Open

$6.96

Previous Close

$6.96

Daily Range

$6.96 - $6.96

52-Week Range

$5.41 - $12.05

Dividend

$0.00

Beta (Volatility)

0.38 (Low)

Price

$6.96

Volume

Open

$6.96

Previous Close

$6.96

Daily Range

$6.96 - $6.96

52-Week Range

$5.41 - $12.05

ADXN News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Addex Therapeutics

Industry

Pharmaceuticals

Sector

Health Care

Employees

CEO

Tim Dyer

Website

www.addextherapeutics.com

Headquarters

Geneva, 1202, CH

ADXN Financials

Key Financial Metrics (TTM)

Gross Margin

-7%

Operating Margin

-10%

Net Income Margin

-24%

Return on Equity

-99%

Return on Capital

-44%

Return on Assets

-92%

Earnings Yield

-1.25%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$8.80M

Shares Outstanding

1.26M

Volume

Avg. Volume

4.29K

Financials (TTM)

Gross Profit

$0.00

Operating Income

$2.69M

EBITDA

$2.69M

Operating Cash Flow

$5.37M

Capital Expenditure

$1.27K

Free Cash Flow

$5.37M

Cash & ST Invst.

$3.35M

Total Debt

$41.99K

Addex Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$142.19K

+9328.8%

Gross Profit

$0.00

-100.0%

Gross Margin

0.00%

N/A

Market Cap

$8.80M

N/A

Market Cap/Employee

$4.40M

N/A

Employees

N/A

Net Income

$1.82M

-51.3%

EBITDA

$647.40K

+44.4%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$2.16M

-34.8%

Accounts Receivable

$51.25K

-90.1%

Inventory

$0.00

N/A

Long Term Debt

$28.96K

-20.8%

Short Term Debt

$7.58K

+5.1%

Return on Assets

-91.79%

N/A

Return on Invested Capital

-43.66%

N/A

Free Cash Flow

$533.20K

-33.3%

Operating Cash Flow

$533.20K

-33.8%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

BCLIBrainstorm Cell Therapeutics Inc.

BCLIBrainstorm Cell Therapeutics Inc.$0.65-2.97%

TCRTAlaunos Therapeutics, Inc.

TCRTAlaunos Therapeutics, Inc.$2.54-2.68%

RADXRadiopharm Theranostics Limited

RADXRadiopharm Theranostics Limited$4.44+0.68%

QNRXQuoin Pharmaceuticals, Ltd.

QNRXQuoin Pharmaceuticals, Ltd.$6.30+1.45%

CDIOCardio Diagnostics Holdings, Inc.

CDIOCardio Diagnostics Holdings, Inc.$1.98+5.32%

ADILAdial Pharmaceuticals, Inc.

ADILAdial Pharmaceuticals, Inc.$1.63+5.16%

NRSNNeuroSense Therapeutics Ltd.

NRSNNeuroSense Therapeutics Ltd.$0.90+0.09%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

CNSPCns Pharmaceuticals

CNSPCns Pharmaceuticals$7.95+2.44%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.21+0.01%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.67-0.01%

XNDUXanadu Quantum Technologies

XNDUXanadu Quantum Technologies$13.94-0.61%

IBITiShares Bitcoin Trust

IBITiShares Bitcoin Trust$45.35+0.02%

NOKNokia

NOKNokia$13.12-0.01%

GBTGGlobal Business Travel Group

GBTGGlobal Business Travel Group$9.34+0.58%

Questions About ADXN

What is the current price of Addex Therapeutics?

Addex Therapeutics is trading at $6.96 per share.

What is the 52-week range for Addex Therapeutics?

Over the past 52 weeks, Addex Therapeutics has traded between $5.41 and $12.05.

How much debt does Addex Therapeutics have?

As of the most recent reporting period, Addex Therapeutics reported total debt of $45,936.027.

How much cash does Addex Therapeutics have on hand?

Addex Therapeutics reported $2.07M in cash and cash equivalents in its most recent financial results.

What is Addex Therapeutics’s dividend yield?

Addex Therapeutics does not currently have a dividend yield.

Addex Therapeutics

Addex Therapeutics Financials at a Glance

ADXN News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Addex Therapeutics

ADXN Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Addex Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About ADXN

What is the current price of Addex Therapeutics?

What is the 52-week range for Addex Therapeutics?

How much debt does Addex Therapeutics have?

How much cash does Addex Therapeutics have on hand?

What is Addex Therapeutics’s dividend yield?

Premium Investing Services